Exclusive-Maker of Walmart, Amazon store-brand baby formulas sees
shortages through rest of 2022
Send a link to a friend
[May 14, 2022] By
Jessica DiNapoli
NEW YORK (Reuters) -Perrigo Company PLC,
which makes store-brand baby formulas for retailers, including Walmart
Inc and Amazon.com Inc, expects shortages and heightened demand to last
for the "balance of the year," Chief Executive Murray Kessler told
Reuters in an interview.
The Biden administration this week has come under increasing pressure to
address a baby formula shortage, which has roots in a February recall of
some formulas by one of the nation's main manufacturers, Abbott
Laboratories.
"We have stepped up and are killing ourselves to do everything we can,"
Kessler said.
Perrigo's formula manufacturing facilities in Ohio and Vermont are now
running at 115% of capacity, Kessler said.
At the request of the U.S. Food and Drug Administration, Perrigo is
focusing on four items, the store-brand versions of Similac Pro
Sensitive and Pro Advance and Enfamil Gentle Ease and Infant, Kessler
said.
The company added that it is making other formulas as well. It also has
a smaller business making some national formula brands, including
Bobbie.
The closure of Abbott's infant-formula plant in Sturgis, Michigan,
exacerbated national pandemic-related shortages, leading to empty
shelves in big box stores and supermarkets and panicked parents.
Abbott's brands include Similac formulas.
Perrigo is working with retailers including Walmart and Target Corp so
they "get something each week," Kessler said. Retailers' allocations are
based on an average of what the retailers received prior to "this
crisis," he said.
Some retailers including CVS Health Corp and Target are rationing baby
formula.
The White House on Thursday announced steps it is taking to alleviate
the shortage, including permitting more imports. President Joe Biden
said on Friday he expects more formula on shelves in weeks.
[to top of second column] |
Empty shelves show a shortage of baby formula at a Target store in
San Antonio, Texas, U.S. May 10, 2022. REUTERS/Kaylee Greenlee Beal
French food and beverage company Danone SA, which also makes infant formulas,
said the "unexpected Abbott Nutrition recall in February has led to a surge in
demand in the U.S. market.
"We are in discussions with the U.S. authorities to see how we can support them
in addressing their shortages.”
Of the total U.S. baby formula market, Perrigo makes up roughly 8%, Kessler
said, adding that it has gained share as it has worked to satisfy the soaring
demand.
Due to "massive inflation," Perrigo raised prices by about 3% in the first
quarter, Kessler said.
The company has ordered materials to meet the heightened level of demand
throughout the year, he said.
Bobbie, a European-style infant formula new to the market, saw its customer
count double the first week after the recall of Abbott formulas, and it has
continued to climb, CEO Laura Modi told Reuters.
Perrigo manufacturers Bobbie's formula, but can only meet about 50% of the
company's demand, Modi said, leading it to stop taking new customers. Perrigo
can meet 100% of Bobbie's current customer needs, she said.
Bobbie has about 70,000 customers.
Abbott closed its manufacturing facility in Michigan after complaints of
bacterial contamination.
The FDA later cited five bacterial infections reported in babies given the
company's formula, including two deaths. Abbott has said its plants are "not
likely the source of infection" and is planning on re-opening the facility in
the next two weeks.
(Reporting by Jessica DiNapoli in New York and Richa Naidu in LondonEditing by
Nick Zieminski and Marguerita Choy)
[© 2022 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |